NASDAQ:ALGN - Align Technology Stock Price, Forecast & News

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) released its quarterly earnings results on Wednesday, January, 29th. The medical equipment provider reported $1.53 earnings per share for the quarter, topping analysts' consensus estimates of $1.40 by $0.13. The medical equipment provider earned $649.80 million during the quarter, compared to analysts' expectations of $646.75 million. Align Technology had a return on equity of 30.06% and a net margin of 18.40%. Align Technology's quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.20 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, April 22nd 2020. View Earnings Estimates for Align Technology.

Align Technology updated its first quarter earnings guidance on Wednesday, January, 29th. The company provided earnings per share (EPS) guidance of $1.19-$1.28 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.42. The company issued revenue guidance of $615-$630 million, compared to the consensus revenue estimate of $656.29 million.

11 analysts have issued 1 year target prices for Align Technology's shares. Their forecasts range from $200.00 to $360.00. On average, they expect Align Technology's share price to reach $270.09 in the next twelve months. This suggests that the stock has a possible downside of 2.4%. View Analyst Price Targets for Align Technology.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Media coverage about ALGN stock has been trending negative this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Align Technology earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the stock's share price in the next few days. View News Stories for Align Technology.

Align Technology saw a decline in short interest during the month of January. As of January 31st, there was short interest totalling 3,430,000 shares, a decline of 8.8% from the January 15th total of 3,760,000 shares. Based on an average trading volume of 768,100 shares, the short-interest ratio is currently 4.5 days. Approximately 4.8% of the shares of the company are short sold. View Align Technology's Current Options Chain.

Some companies that are related to Align Technology include Cooper Companies (COO), West Pharmaceutical Services (WST), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Micron Technology (MU), Adobe (ADBE), Paypal (PYPL), Visa (V), salesforce.com (CRM), Boeing (BA) and Mastercard (MA).

Align Technology's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Wealth Quarterback LLC (20.63%), Edgewood Management LLC (5.96%), State Street Corp (3.93%), Sands Capital Management LLC (3.71%), Polen Capital Management LLC (3.59%) and Renaissance Technologies LLC (3.31%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including UBS Asset Management Americas Inc., Echo Street Capital Management LLC, Goldman Sachs Group Inc., AQR Capital Management LLC, Logan Capital Management Inc., Jennison Associates LLC, Factory Mutual Insurance Co. and Bank of New York Mellon Corp. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Renaissance Technologies LLC, Alliancebernstein L.P., Veritas Investment Management LLP, Champlain Investment Partners LLC, Amundi Pioneer Asset Management Inc., FMR LLC and Capital World Investors. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $276.76.

Align Technology has a market capitalization of $21.81 billion and generates $2.41 billion in revenue each year. The medical equipment provider earns $442.78 million in net income (profit) each year or $4.96 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.

The official website for Align Technology is http://www.aligntech.com/.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]